Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1165)
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
593
Price
$549.49
Total Value
$325.85K
Shares Held After
46,422
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,481
Price
$548.42
Total Value
$812.22K
Shares Held After
47,015
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
935
Price
$547.11
Total Value
$511.55K
Shares Held After
48,496
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
2,627
Price
$546.42
Total Value
$1.44M
Shares Held After
49,431
% of Holdings
5.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
374
Price
$545.27
Total Value
$203.93K
Shares Held After
52,058
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
840
Price
$543.89
Total Value
$456.87K
Shares Held After
52,432
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
200
Price
$539.76
Total Value
$107.95K
Shares Held After
53,272
% of Holdings
0.4%
Summit Therapeutics Inc. (SMMT)
Soni Manmeet Singh — Director
Shares
25,000
Price
$14.43
Total Value
$360.75K
Shares Held After
3,123,603
% of Holdings
0.8%
Summit Therapeutics Inc. (SMMT)
Soni Manmeet Singh — Director
Shares
25,000
Price
$14.46
Total Value
$361.50K
Shares Held After
3,098,603
% of Holdings
0.8%
Alkermes plc. (ALKS)
Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Shares
2,034
Price
$43.05
Total Value
$87.56K
Shares Held After
229,524
% of Holdings
0.9%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
714
Price
$1.55
Total Value
$1.11K
Shares Held After
63,890
% of Holdings
1.1%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
7,069
Price
$1.55
Total Value
$10.96K
Shares Held After
632,835
% of Holdings
1.1%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
5,500
Price
$78.71
Total Value
$432.90K
Shares Held After
205,648
% of Holdings
2.6%
Dyne Therapeutics, Inc. (DYN)
Posner Brian S — Director
Shares
2,500
Price
$17.48
Total Value
$43.70K
Shares Held After
22,500
% of Holdings
11.1%
Ainos, Inc. (AIMD)
chiang yao-chung — Director
Shares
2,000
Price
$2.13
Total Value
$4.26K
Shares Held After
7,779
% of Holdings
25.7%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
2,566
Price
$102.27
Total Value
$262.42K
Shares Held After
62,344
% of Holdings
4.0%
INSMED Inc (INSM)
Bonstein Sara — Chief Financial Officer
Shares
2,404
Price
$102.27
Total Value
$245.86K
Shares Held After
69,082
% of Holdings
3.4%
INSMED Inc (INSM)
Lewis William — Director
Shares
7,605
Price
$102.27
Total Value
$777.76K
Shares Held After
265,432
% of Holdings
2.8%
INSMED Inc (INSM)
Smith Michael Alexander — Chief Legal Officer
Shares
2,159
Price
$102.27
Total Value
$220.80K
Shares Held After
39,454
% of Holdings
5.2%
Aldeyra Therapeutics, Inc. (ALDX)
Brady Todd C — Director
Shares
250,000
Price
$1.67
Total Value
$418.45K
Shares Held After
1,721,298
% of Holdings
14.5%
INSMED Inc (INSM)
Adsett Roger — Chief Operating Officer
Shares
2,370
Price
$102.27
Total Value
$242.38K
Shares Held After
98,603
% of Holdings
2.3%
Xeris Biopharma Holdings, Inc. (XERS)
PERSKY MARLA — Director
Shares
15,500
Price
$5.90
Total Value
$91.43K
Shares Held After
126,500
% of Holdings
10.9%
Editas Medicine, Inc. (EDIT)
Parison Amy — SVP, Chief Financial Officer
Shares
464
Price
$2.70
Total Value
$1.25K
Shares Held After
14,970
% of Holdings
3.0%
Editas Medicine, Inc. (EDIT)
O'Neill Gilmore Neil — Director
Shares
15,380
Price
$2.70
Total Value
$41.54K
Shares Held After
248,313
% of Holdings
5.8%
Editas Medicine, Inc. (EDIT)
Burkly Linda — EVP, CHIEF SCIENTIFIC OFFICER
Shares
731
Price
$2.70
Total Value
$1.97K
Shares Held After
67,297
% of Holdings
1.1%
uniQure N.V. (QURE)
Kaye Jack — Director
Shares
2,645
Price
$30.01
Total Value
$79.38K
Shares Held After
20,439
% of Holdings
11.5%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
2,323
Price
$4.26
Total Value
$9.90K
Shares Held After
179,186
% of Holdings
1.3%
OCULAR THERAPEUTIX, INC (OCUL)
Waheed Nadia — Chief Medical Officer
Shares
14,828
Price
$8.27
Total Value
$122.63K
Shares Held After
300,079
% of Holdings
4.7%
GENELUX Corp (GNLX)
Smalling Ralph — Head of Regulatory
Shares
192
Price
$2.93
Total Value
$562.56
Shares Held After
67,611
% of Holdings
0.3%
MediWound Ltd. (MDWD)
SHAMIR NACHUM — Director
Shares
5,825
Price
$14.00
Total Value
$81.55K
Shares Held After
55,815
% of Holdings
10.4%
MediWound Ltd. (MDWD)
SHAMIR NACHUM — Director
Shares
175
Price
$13.97
Total Value
$2.45K
Shares Held After
49,990
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
142
Price
$551.97
Total Value
$78.38K
Shares Held After
40,513
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$551.23
Total Value
$44.10K
Shares Held After
40,655
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
842
Price
$550.06
Total Value
$463.15K
Shares Held After
40,735
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,956
Price
$549.15
Total Value
$1.07M
Shares Held After
41,577
% of Holdings
4.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,226
Price
$548.04
Total Value
$1.22M
Shares Held After
43,533
% of Holdings
4.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,664
Price
$546.96
Total Value
$910.14K
Shares Held After
45,759
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,050
Price
$546.01
Total Value
$573.31K
Shares Held After
47,423
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,139
Price
$545.22
Total Value
$621.01K
Shares Held After
48,473
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
401
Price
$543.89
Total Value
$218.10K
Shares Held After
49,612
% of Holdings
0.8%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Bumpus Namandje — Director
Shares
4,386
Price
$3.54
Total Value
$15.53K
Shares Held After
43,171
% of Holdings
9.2%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
15,000
Price
$10.76
Total Value
$161.36K
Shares Held After
147,680
% of Holdings
9.2%
Alpha Tau Medical Ltd. (DRTS)
Levy Raphi — Chief Financial Officer
Shares
17,500
Price
$10.90
Total Value
$190.76K
Shares Held After
162,680
% of Holdings
9.7%
Spyre Therapeutics, Inc. (SYRE)
Sloan Sheldon — Chief Medical Officer
Shares
8,333
Price
$75.00
Total Value
$624.98K
Shares Held After
0
% of Holdings
100.0%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
6,100
Price
$69.69
Total Value
$425.12K
Shares Held After
767,780
% of Holdings
0.8%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
2,000
Price
$68.74
Total Value
$137.47K
Shares Held After
773,880
% of Holdings
0.3%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
1,500
Price
$67.67
Total Value
$101.51K
Shares Held After
775,880
% of Holdings
0.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
400
Price
$66.37
Total Value
$26.55K
Shares Held After
777,380
% of Holdings
0.1%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
29,749
Price
$0.42
Total Value
$12.49K
Shares Held After
482,776
% of Holdings
5.8%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Saxena Nishant C — Chief Business Officer
Shares
9,000
Price
$7.58
Total Value
$68.22K
Shares Held After
75,300
% of Holdings
12.0%
Showing 701–750 of 1165 transactions (page 15 of 24)